| ERDAFITINIB Basic information | |
| Product Name: | Erdafitinib |
| Synonyms: | Erdafitinib;Erdafitinib(JNJ-42756493);N-(3,5-dimethoxyphenyl)-N’-(1-methylethyl)-N-[3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine;N1-(3,5-Dimethoxyphenyl)-N2-(1-methylethyl)-N1-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-1,2-ethanediamine;SuftalanZine;N-(3,5-Dimethoxyphenyl)-N’-isopropyl-N-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-1,2-ethanediamine;N1-(3,5-dimethoxyphenyl)-N2-isopropyl-N1-(3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl)ethane-1,2-diamine;ERDAFITINIB;JNJ-42756493;JNJ42756493;JNJ42756493 |
| CAS: | 1346242-81-6 |
| MF: | C25H30N6O2 |
| MW: | 446.54 |
| EINECS: | 610-261-8 |
| Product Categories: | Bioactive molecule -API; Active pharmaceutical ingredients and intermediates; Active pharmaceutical ingredient Chemicals; Chemical engineering API |
| Mol File: | 1346242-81-6.mol |
| Introduction | Erdatinib (JNJ-42756493) is a pan-fibroblast growth factor receptor (FGFR) kinase inhibitor. |
| Erdafitinib Chemical Properties | |
| Melting point | 136-140°C |
| Boiling point | 662.3±55.0 °C(Predicted) |
| density | 1.20±0.1 g/cm3(Predicted) |
| pKa | 9.45±0.29(Predicted) |
| storage temp. | -20°C Freezer, Under inert atmosphere |
| form | Powder |
| color | Sticky yellow |